ArticleScientific reports2025
Graph neural network model using radiomics for lung CT image segmentation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Early detection of lung cancer is critical for improving treatment outcomes, and automatic lung image segmentation plays a key role in diagnosing lung-related diseases such as cancer, COVID-19, and respiratory disorders. Challenges include overlapping anatomical structures, complex pixel-level feature fusion, and intricate morphology of lung tissues all of which impede segmentation accuracy. To address these issues, this paper introduces GEANet, a novel framework for lung segmentation in CT images. GEANet utilizes an encoder-decoder architecture enriched with radiomics-derived features. Additionally, it incorporates Graph Neural Network (GNN) modules to effectively capture the complex heterogeneity of tumors. Additionally, a boundary refinement module is incorporated to improve image reconstruction and boundary delineation accuracy. The framework utilizes a hybrid loss function combining Focal Loss and IoU Loss to address class imbalance and enhance segmentation robustness. Experimental results on benchmark datasets demonstrate that GEANet outperforms eight state-of-the-art methods across various metrics, achieving superior segmentation accuracy while maintaining computational efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.